MEI Pharma, Inc. (MEIP) Reports Q1 Loss, Tops Revenue Estimates
MEI Pharma, Inc. (MEIP) came out with a quarterly loss of $0.13 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items.
A quarter ago, it was expected…
